Clinical Trial Update: Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria [NA]

View source ↗

Summary

A clinical trial investigating neuroimaging and neurocognitive responses to sapropterin dihydrochloride in phenylketonuria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: Children's National Research Institute | Conditions: PKU | NA | Status: WITHDRAWN